| NEW YORK
NEW YORK Dec 17 IMS Health Inc has hired
JPMorgan Chase & Co Inc to lead a proposed initial
public offering that could value the private equity-owned
healthcare information company at close to $10 billion,
according to people familiar with the matter.
TPG Capital LP, Canada Pension Plan Investment Board (CPPIB)
and Leonard Green & Partners LP, which bought IMS in 2010 for
$5.2 billion, including debt, chose JPMorgan as the lead
underwriter after interviewing investment banks late last week,
the people said.
Morgan Stanley and Goldman Sachs would also
lead the planned offering, which is planned for 2014, the people
said, asking not to be named because the matter is not public.
While the private equity owners could also explore an
outright sale of Danbury, Connecticut-based IMS to another
company, a public offering is a more likely outcome, some of the
IMS Health, TPG, CPPIB and Goldman Sachs declined to comment
while Leonard Green, JPMorgan and Morgan Stanley did not
immediately respond to requests for comment.
IMS Health provides prescription data to the pharmaceutical
industry, medical device makers, government agencies and other
companies in the healthcare sector. Founded in 1954, the company
has over 5,000 clients and operates in more than 100 countries
according to its website.
The company has posted lackluster revenue growth since 2009,
yet cost cuts, acquisitions and restructuring initiatives have
enabled it to grow its free cash flow, after capital
expenditures, to more than $150 million this year, according to
Moody's Investors Service Inc.
Its private equity owners have taken advantage of the strong
cash flow to draw $1.95 billion in dividends from the company in
the last 14 months by having it borrow, according to Moody's.
Private equity firms have sought to unload their portfolio
companies this year as stock markets have enjoyed strong
This year ranked as the strongest for U.S. IPOs since 2000
by dollar volume, according to Thomson Reuters data, as large
floats such as Hilton Worldwide Holdings and Plains GP
Holdings lifted deal proceeds up 21 percent from 2012
to $56.4 billion.